Are immunoconjugates useful for therapy with autoimmune diseases?
- 1 February 1997
- journal article
- review article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 19 (2), 83-93
- https://doi.org/10.1016/s0192-0561(97)00012-x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Evaluation of a CD5-specific immunotoxin for treatment of acute graft- versus-host disease after allogeneic marrow transplantationBlood, 1996
- In vivo treatment of Heymann's Nephritis using a cytotoxic protein‐toxin conjugateFEBS Letters, 1995
- Interleukin‐2 diphtheria fusion protein (dab486il‐2) in refractory rheumatoid arthritis a double‐blind, placebo‐controlled trial with open‐label extensionArthritis & Rheumatism, 1995
- Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basisNature Medicine, 1995
- Autoimmune versus inflammatory type I diabetes: a controversy?Immunology Today, 1995
- Suppression of experimental systemic lupus erythematosus (SLE) with specific anti-idiotypic antibody–saporin conjugateClinical and Experimental Immunology, 1994
- Anti‐arthritic effects demonstrated by an interleukin‐2 receptor‐targeted cytotoxin (DAB486IL‐2) in rat adjuvant arthritisEuropean Journal of Immunology, 1992
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990
- [31] Inhibition of autoimmune reactivity against acetylcholine receptor with idiotype-specific immunotoxinsMethods in Enzymology, 1989
- Streptozotocin-Induced Pancreatic Insulitis: New Model of Diabetes MellitusScience, 1976